On Tuesday, the UK-based website Pharma Boardroom which provides free pharmaceutical industry trends, news, and reports all over the globe, released a new reference entitled Morocco Pharmaceuticals Report.
The report found the national pharmaceutical industry to be strong, with a well-developed base of local producers that “today manufacture products to the highest international standards.”
It also noted that “Morocco has quietly become the second largest African exporter of drugs right below South Africa.”
Statistics say Morocco exports between 7-8%of its national pharma production; an increase of 21.7% in turnover since 2012-2013.
Pharma Boardroom informed this increase is due to the advances that have been made by Moroccan pharmaceutical companies which have exported for years, “benefiting from the vision of King Mohammed VI to open Morocco to the South.”
Along with their continuous expansion southwards, the Moroccan companies are now eyeing more developed markets in Europe and the U.S.
Ali Bennis, head of Laboratories Laprophan, one of the leading Moroccan pharmaceutical companies, said his company is “targeting Europe and North America especially for our patented medicines”.
“We can benefit from the free-trade agreement with the United States to enhance our exports to this high-potential pharmaceutical market,” he added.
No comments:
Post a Comment